Several studies have indicated that the overactivation of the mTOR pathway can disrupt the IRS1/PI3K/AKT signaling pathway, resulting in hepatic gluconeogenesis and glycogen breakdown, while also inhibiting glucose uptake in muscle and adipose tissue, thereby exacerbating T2DM and IR (Bu et al. 2025). Here, MTOR is linked to type 2 diabetes mellitus.